Literature DB >> 29466836

TGFβ1-induced expression of caldesmon mediates epithelial-mesenchymal transition.

Sandeep M Nalluri1, Joseph W O'Connor1, Gage A Virgi1, Samantha E Stewart2, Dan Ye1, Esther W Gomez1,3.   

Abstract

Epithelial-mesenchymal transition (EMT) is an important process that mediates organ development and wound healing, and in pathological contexts, it can contribute to the progression of fibrosis and cancer. During EMT, cells exhibit marked changes in cytoskeletal organization and increased expression of a variety of actin associated proteins. Here, we sought to determine the role of caldesmon in mediating EMT in response to transforming growth factor (TGF)-β1. We find that the expression level and phosphorylation state of caldesmon increase as a function of time following induction of EMT by TGFβ1 and these changes in caldesmon correlate with increased focal adhesion number and size and increased cell contractility. Knockdown and forced expression of caldesmon in epithelial cells reveals that caldesmon expression plays an important role in regulating the expression of the myofibroblast marker alpha smooth muscle actin. Results from these studies provide insight into the role of cytoskeletal associated proteins in the regulation of EMT and may suggest ways to target the cell cytoskeleton for regulating EMT processes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytoskeleton; focal adhesions; myofibroblast; traction force microscopy

Mesh:

Substances:

Year:  2018        PMID: 29466836     DOI: 10.1002/cm.21437

Source DB:  PubMed          Journal:  Cytoskeleton (Hoboken)        ISSN: 1949-3592


  4 in total

Review 1.  A Tale of Two States: Normal and Transformed, With and Without Rigidity Sensing.

Authors:  Michael Sheetz
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-14       Impact factor: 13.827

2.  Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression.

Authors:  Madhurima Paul; Tamal Kanti Gope; Priyanka Das; Rupasri Ain
Journal:  BMC Cancer       Date:  2022-05-31       Impact factor: 4.638

Review 3.  Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.

Authors:  Alya R Alnuaimi; Vidhya A Nair; Lara J Bou Malhab; Eman Abu-Gharbieh; Anu Vinod Ranade; Gianfranco Pintus; Mohamad Hamad; Hauke Busch; Jutta Kirfel; Rifat Hamoudi; Wael M Abdel-Rahman
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

Review 4.  Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Authors:  Alicia M Hidalgo-Estévez; Konstantinos Stamatakis; Marta Jiménez-Martínez; Ricardo López-Pérez; Manuel Fresno
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.